-+ 0.00%
-+ 0.00%
-+ 0.00%

Avalo Therapeutics Enters Up to $200 Million At-the-Market Offering Agreement With Jefferies

PUBT·11/05/2026 13:14:18
Listen to the news
Avalo Therapeutics Enters Up to $200 Million At-the-Market Offering Agreement With Jefferies
  • Avalo Therapeutics entered an agreement with Jefferies on November 5, 2026, to sell up to $200 million of common stock through at-the-market offerings.
  • Jefferies will receive a commission of up to 3% of gross sale proceeds.
  • Share sales remain at the company's discretion, with no obligation to sell.
  • The prior sales agreement with TD Cowen, dated June 5, 2025, terminated effective November 5, 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Avalo Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001104659-26-123079), on November 05, 2026, and is solely responsible for the information contained therein.